Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail V Matthews

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
Antiviral Therapy|May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirGail V Matthews, David A Cooper, Gregory J Dore
Hepatology (Baltimore, Md.)|June 12, 2014
Reply: To PMID 24449403Jacinta A Holmes, Gail V Matthews, Alexander J Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative ReviewMarianne Martinello, Susanna Naggie, Juergen Kurt Rockstroh, et al.
AIDS Reviews|May 20, 2016
Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-AnalysisMarianne Martinello, Janaki Amin, Gail V Matthews, et al.
Infectious Disease Clinics of North America|May 21, 2018
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject DrugsMarianne Martinello, Gregory J Dore, Gail V Matthews, et al.
The International Journal on Drug Policy|August 22, 2022
Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative studyAlison D Marshall, Marianne Martinello, Carla Treloar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
AIDS (London, England)|September 22, 2007
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et alGail V Matthews, Margaret Hellard, John Kaldor, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Hepatology Communications|March 30, 2023
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021Joanne Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
Antiviral Therapy|May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirGail V Matthews, David A Cooper, Gregory J Dore
Hepatology (Baltimore, Md.)|June 12, 2014
Reply: To PMID 24449403Jacinta A Holmes, Gail V Matthews, Alexander J Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative ReviewMarianne Martinello, Susanna Naggie, Juergen Kurt Rockstroh, et al.
AIDS Reviews|May 20, 2016
Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-AnalysisMarianne Martinello, Janaki Amin, Gail V Matthews, et al.
Infectious Disease Clinics of North America|May 21, 2018
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject DrugsMarianne Martinello, Gregory J Dore, Gail V Matthews, et al.
The International Journal on Drug Policy|August 22, 2022
Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative studyAlison D Marshall, Marianne Martinello, Carla Treloar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
AIDS (London, England)|September 22, 2007
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et alGail V Matthews, Margaret Hellard, John Kaldor, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Hepatology Communications|March 30, 2023
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021Joanne Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Pageof 19